Anchyra Partners »

Lineage Cell Therapeutics In shares owned by Anchyra Partners

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Anchyra Partners from 13F filings

Historical chart of Anchyra Partners investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Anchyra Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Anchyra Partners

Quarter filed Position value Share count Share price at filing
2026-09-30 $15k 15k 0.96

More positions owned by Anchyra Partners

T. Rowe Price (TROW)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 3000 Etf (IWV)
Amazon (AMZN)
Micron Technology (MU)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs (GLD)
Arista Networks Com Shs (ANET)
Navios Maritime Partners Com Unit Lpi (NMM)
Marvell Technology (MRVL)

View all positions for Anchyra Partners

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
UBS Group

View all funds holding Lineage Cell Therapeutics In